Revised Blood Donor Guidelines India 2025

Revised Blood Donor Selection & Referral Criteria in India (February 2025 Guidelines)

Complete Official Clause-by-Clause Master Reference Guide for the NBTC & DGHS Guidelines.

22 min read Ministry of Health & Family Welfare

In February 2025, the National Blood Transfusion Council (NBTC) and the Director General of Health Services (DGHS), Ministry of Health & Family Welfare (MoHFW), Government of India, New Delhi issued the revised comprehensive national regulatory document titled "Guidelines for Blood Donor Selection and Blood Donor Referral 2025". This master guide provides an exhaustive clause-by-clause breakdown of every single section, physical parameter, medical deferral condition (all medical conditions), legal mandate, personnel responsibility, and ICTC referral mechanism outlined in the official publication.

Official Document Details & Metadata:

  • Document Title: Guidelines for Blood Donor Selection and Blood Donor Referral
  • Publishing Authority: National Blood Transfusion Council (NBTC) & DGHS
  • Ministry: Ministry of Health and Family Welfare, Government of India
  • Publication Year: February 2025 (New Delhi)
  • Status: Active National Standard
  • Statutory Reference: Drugs and Cosmetics Act 1940 & Rules 1945

🎯 1. Rationale & Objectives: Why Were the Guidelines Revised in 2025?

Official DGHS guidelines detail the underlying necessity for updating India's blood donor selection criteria:

1
100% Voluntary Non-Remunerated Blood Donors (VNRBD)

To eliminate commercial paid blood donation completely and systematically phase out family replacement donation, which carries statistically higher infection risks.

2
Protection of Donor Safety & Retention

To ensure that donating blood causes zero physical or psychological harm to the donor, preventing anemia, vasovagal collapse, or organ strain, and building a regular pool of repeat voluntary donors.

3
Updated TTI Window Period Safety

To reflect advanced diagnostic window periods for Transfusion Transmitted Infections (HIV, HBV, HCV, Syphilis, Malaria) and minimize recipient infection risks.

4
National Recall & Referral Standardization

To mandate that any blood donor testing initial sero-reactive is not merely turned away, but provided confidential post-test counseling and linked directly to NACO ICTC / ART treatment centers.

📋 2. The 5-Stage Blood Donor Counseling & Consent Framework

The national guidelines outline the mandatory 5-stage workflow for every blood center in India:

  • Stage 1: Pre-Donation Information: Educating prospective donors using simple Educational & Communication (IEC) leaflets regarding blood components, TTI modes of transmission, window periods, and self-deferral rights.
  • Stage 2: Pre-Donation Counseling & Questionnaire: One-on-one confidential history taking. Donors sign the Informed Consent Form acknowledging 5 explicit points:
    1. Donation is a voluntary act with no inducement or remuneration.
    2. Donation is a medical procedure and associated risks are accepted.
    3. Recovered plasma may be sent for fractionation to prepare plasma-derived medicines (e.g., Immunoglobulins, Albumin).
    4. Blood will be mandatorily screened for HIV, Hepatitis B, Hepatitis C, Syphilis, and Malaria.
    5. The donor wishes to be confidentially informed of any abnormal test results.
  • Stage 3: Counseling During Donation: Ensuring donor comfort during venepuncture, mitigating vasovagal fainting anxiety, and fostering trust.
  • Stage 4: Post-Donation Information & Self-Care: Instructions to drink plenty of fluids, avoid heavy physical labor/driving for 24h, remove bandage after 6 hours, and report adverse reactions.
  • Stage 5: Post-Donation Recall & ICTC Referral: Confidential in-person notification and referral for sero-reactive donors.

📊 3. Master Physical & Demographic Selection Criteria

The core physical criteria required for every prospective donor are summarized below:

# Condition / Parameter Official 2025 DGHS Criteria 1-Line Summary & Rationale
1 Well-being & Disability Good health, mentally alert. Differently-abled donors (sight/communication) accepted if valid consent established. Promotes inclusive donation while guaranteeing full understanding and consent.
2 Age Limits 18 to 65 years. First-time donors: max 60 years. Apheresis: 18 to 60 years. Legal consent age minimum; protects senior donors from cardiovascular strain.
3 Weight & Volume 350 mL whole blood: 45 kg. 450 mL: >55 kg. SDP Apheresis: 50 kg. Double Red Cell: 60 kg. Ensures collection never exceeds 13% of total blood volume to prevent shock.
4 Donation Interval Males: 3 months (90 days). Females: 4 months (120 days). SDP: 48 hours (max 24/year). Allows red cell and serum ferritin replenishment; accounts for female menses loss.
5 Blood Pressure Systolic: 100 – 140 mmHg. Diastolic: 60 – 90 mmHg (No dose change in 28 days). Excludes hypertension with organ damage or un-stabilized medication.
6 Pulse Rate 60 to 100 bpm (regular). Athlete bradycardia (50-59 bpm) accepted if fit. Verifies normal cardiac rhythm and absence of acute stress or arrhythmia.
7 Body Temperature Afebrile (≤ 37°C / 98.4°F). Excludes donors with active fever or acute systemic infections.
8 Respiration Free from acute respiratory disease. Prevents donor dyspnea and transmission of airborne viral infections.
9 Hemoglobin (Hb) ≥ 12.5 g/dL whole blood. ≥ 14.0 g/dL double red cell. Thalassemia trait accepted if Hb ok. Prevents donor anemia; verifies red cell oxygen-carrying capacity.
10 Pre-Donation Meal Not fasting. Meal taken within 4 hours prior. Maintains blood glucose levels to prevent vasovagal fainting.
11 Alcohol Intake No regular heavy intake; no signs of acute intoxication. Prevents impaired consent and altered plasma alcohol concentration.
12 Hazardous Duty Aircrew, long-distance drivers, miners, divers: No donation within 12h before duty; no duty for 24h post. Protects public safety and prevents delayed fainting during critical work.
13 Risk Behavior MSM, Transgender, FSW, IDU, multiple partners, prison inmates: Permanently deferred. High statistical risk for blood-borne TTI transmission during window periods.
14 Travel & Residence No travel to endemic unscreened disease zones. Foreign residents accepted if criteria met. Prevents introduction of exotic blood-borne pathogens without local screening tests.
15 Donor Skin Phlebotomy arm free of skin lesions or needle puncture scars indicative of narcotics. Prevents bacterial contamination during needle insertion and screens for IDU.

📖 4. Complete Clause-by-Clause Deferral Summary

The complete master medical condition listing. Below is a 1-to-2 line summary of every single condition:

🌸 Women's Reproductive Status

Pregnancy: Deferred for 12 months after delivery to rebuild iron stores. | Abortion: Deferred for 6 months post-abortion. | Breastfeeding: Deferred for 12 months post-delivery and during active lactation. | Menstruation: Deferred only for the active period of menses if feeling unwell or experiencing heavy bleeding.

🤒 Non-Specific Illness & Respiratory

Fever/Malaise: Defer until symptoms subside; defer 28 days if fever with joint pain/rashes occurs. | Cold/Flu: Defer until afebrile and symptom-free. | Sinusitis: Chronic sinusitis accepted unless on antibiotics. | Asthma: Accepted if asymptomatic on non-steroid/inhaled meds; 14 days temporary deferral for acute flare or oral steroids; permanent deferral for severe COPD.

🔪 Surgeries & Dental Interventions

Major Surgery: Defer 12 months post-recovery (hospitalization/anesthesia/blood loss). | Minor Surgery: Defer 3 months post-recovery. | Blood Transfusion Recipient: Defer 12 months. | Open Heart / Bypass / Cancer Surgery: Permanently deferred. | Dental: Scaling/cleaning (48h), Root canal/extraction (14 days), Jaw reconstruction (12 months).

❤️ Cardiovascular & Heart Diseases

Heart Attack, Angina, CAD, Cardiac Meds, Hypertensive Heart Disease, Rheumatic Heart Disease: Permanently deferred due to high risk of cardiac ischemia during blood volume reduction.

🧠 Neurological & Psychiatric Disorders

Migraine: Accept if mild and < 1/week. | Epilepsy/Seizures: Accept if seizure-free and off medication for 3+ years; organic cause permanently deferred. | Schizophrenia: Permanently deferred. | Anxiety & Depression: Accept if stable on donation day regardless of medication.

💊 Endocrine & Metabolic Disorders

Diabetes: Diet/oral hypoglycemics accepted if stable 4 weeks; insulin-dependent or organ complications permanently deferred. | Thyroid: Hypothyroidism on stable dose (8 weeks) accepted; thyrotoxicosis/cancer permanently deferred. | PCOS: Accepted if well. | Other Endocrine: Permanently deferred.

🟡 Liver & Hepatitis Infections

Hepatitis: Hep B/C permanently deferred; Hep A/E deferred 12 months post-recovery. | Partner of Hep B/C: Permanently deferred. | Tattoos/Piercings/Acupuncture: Deferred for 12 months. | Partner of Transfusion Recipient: Deferred 12 months. | Jaundice Acute: Defer 12 months after resolution. | Chronic Liver Failure: Permanently deferred.

🦠 Infectious Diseases & STIs

HIV Risk / PLHA Partner / AIDS Symptoms: Permanently deferred. | Syphilis / Gonorrhea: Permanently deferred. | Measles/Mumps/Chickenpox: Defer 2 weeks post-recovery. | Malaria: Defer 3 months post-recovery. | Typhoid: Defer 12 months. | Dengue/Chikungunya/Zika: Defer 6 months post-recovery (Zika travel 28d). | Tuberculosis: Defer 2 years post-cure. | Leishmaniasis / Leprosy: Permanently deferred. | Kidney/UTI: Conjunctivitis (illness period); Osteomyelitis (2 years post-cure); Pyelonephritis (6 months); UTI/Cystitis (2 weeks); Chronic Renal Failure (Permanently deferred).

🩸 GI, Autoimmune, Hematology & Medications

Diarrhea: Defer 2 weeks post-recovery. | GI Endoscopy: 7 days if no biopsy; 28 days for benign biopsy; permanent for malignancy. | GERD/Hiatus Hernia: Accept; bleeding ulcer permanently deferred. | Lupus/Scleroderma/RA: Permanently deferred. | Polycythemia: Primary permanent; secondary accept if Hb<18.5 /16.5. | Malignancy & Bleeding Disorders: Permanently deferred. | Vaccines: Non-live/Toxoids (14 days); Live attenuated (28 days); Anti-rabies animal bite/HBIG (1 year). | Drugs: OCPs/Paracetamol/Vitamins (Accept); Aspirin (3 days for SDP); Antibiotics/Clopidogrel (2 weeks); Isotretinoin/Finasteride (28 days); Dutasteride (6 months); Acitretin (3 years); Etretinate/Insulin/Cytotoxic (Permanently deferred).

🏥 5. Recall & ICTC Referral Mechanism for Sero-Reactive Donors

The national guidelines standardize the referral protocol for blood centers when a donated blood unit tests initial sero-reactive for HIV, Hepatitis B, Hepatitis C, or Syphilis:

Official 4-Step Referral Workflow:

  1. Strategy I Triage: Reactive units are immediately quarantined and discarded. The result is documented as initial sero-reactive.
  2. In-Person Confidential Recall: Test results are NEVER communicated over the phone or SMS. The donor is invited via a confidential sealed registered letter for an in-person appointment.
  3. Post-Donation Counseling: The Medical Officer provides empathetic counseling in a private room, explains the difference between screening reactivity and diagnostic confirmation, and issues the official Annexure 2 Referral Slip.
  4. 3-Attempt Shared Confidentiality Rule: If the donor fails to appear, up to 3 weekly contact attempts are made. Unreached cases are confidentially referred to the NACO District ICTC Link Worker to prevent loss to care.

👥 6. Annexures & Blood Center Personnel Responsibilities (Pages 19 – 33)

The concluding annexures of the February 2025 document establish administrative and operational guidelines:

  • Annexure 1 (Donor Questionnaire): Standardized bilingual form covering demographics, medical history checklist, and physical examination metrics.
  • Annexure 2 & 3 (Referral & Consent Forms): Official referral documentation and donor acknowledgment consent for ICTC linkage.
  • Annexure 4 (Duties of Personnel): Defines legal responsibilities of the Medical Officer (final selection call), Donor Counselor (pre/post test counseling), Nursing/Technical Staff (phlebotomy & TTI screening), and Camp Organizers.
  • Annexure 5 (Counseling Checklist): Standard operating procedures for donor education and retention.
  • Statutory References: Formulated under the legal authority of the Drugs and Cosmetics Act 1940 & Rules 1945, supported by NACO and WHO blood transfusion safety standards.

7. Frequently Asked Questions (FAQs)

Q1: What is the official source of these revised blood donation rules?

The guidelines were published in February 2025 by the National Blood Transfusion Council (NBTC) and Director General of Health Services (DGHS), Ministry of Health & Family Welfare, Government of India, New Delhi.

Q2: Why was replacement blood donation phased out in the 2025 guidelines?

Family replacement donors often donate under coercion or stress, leading to non-disclosure of high-risk behaviors. Voluntary repeat donors have statistically lower rates of Transfusion Transmitted Infections (TTIs).

Q3: Where can I read deep-dive articles for specific conditions like tattoos or diabetes?

Use our cluster sub-blog links below to access dedicated, deep-dive articles covering tattoos/surgeries, diabetes/high BP, medication charts, women's health rules, and TTI recall protocols.

Become a Registered Voluntary Blood Donor

Join the LifeSavers United voluntary donor network today and help save lives across India.